Get started

Buy-sell-signals

EUR/USD: Will It Recover or Continue Downtrend?Looking at the daily chart of EUR/USD, I see that the pair is moving within a clear bearish channel. Currently, the price is hovering around 1.0297, near the center line of the channel. The EMA 34 and EMA 89 are still sloping down, confirming the long-term downtrend. However, a small divergence at the support level suggests a potential short-term recovery. It is worth noting that the price is testing a dynamic resistance zone, near the EMA 34, around 1.0300. If the price fails to break above this level, selling pressure could increase, dragging the price down to the 1.0200 area, or even the bottom of the channel around 1.0100. Conversely, if the price breaks above the EMA 34 and breaks the channel, the next target could be the 1.0400 area.
by nini_gone
USD/JPY: Consolidation Ahead of Big MoveLooking at the 4-hour chart of USD/JPY, I see the pair is currently trading around 155.79, with a notable reaction at the support area near 155.50. The 34 EMA and 89 EMA have started to widen their gap, indicating that the bearish pressure is still in place. However, the 155.50 price zone acts as an important psychological support, creating a temporary balance between buyers and sellers. The 34 EMA acts as dynamic resistance near 156.20. If the price fails to break above this level, the downtrend is likely to continue. A break below 155.50 could drag the price to test deeper support at 154.80 – a strong support level in previous sessions. Conversely, if the price breaks above the 34 EMA, the pair could test the higher resistance at 156.80, near the 89 EMA.
by nini_gone
GBP/USD: Consolidation at Key SupportLooking at the 4-hour chart of GBP/USD, I see that the pair is currently trading around 1.2202, with signs of consolidation at a strong support zone. The 34 EMA and 89 EMA are still sloping down, indicating that the bearish bias is still dominant. However, the gap between the price and the EMA is narrowing, which could be a sign that the bearish pressure is waning. In addition, the pair has successfully tested the 1.2170 support zone in recent sessions, creating a solid foundation for a short-term recovery. To break this consolidation, the price needs to overcome the dynamic resistance at the 34 EMA, located around 1.2230. If this happens, the next target will be the 1.2300 zone – a strong psychological resistance.
by nini_gone
Gold Gains Amid Low US Inflation – More Upside Ahead? Looking at the gold price action on the 4-hour chart, I see some technical signals supporting the possibility of a price increase. Currently, the price is hovering around $2,699 and maintaining above the EMA 34 ($2,693) and EMA 89 ($2,672). This shows that the uptrend is still dominant. At the same time, the price bounced after touching near the EMA 34 in the recent session, reinforcing the important support role of this area. The arrangement of the EMAs still supports the uptrend, with the EMA 34 above the EMA 89. This combined with the recovery momentum from technical support creates expectations that the price will test the important resistance zone at $2,728. A break of this level would open the possibility of a price increase to the $2,750 area and higher. However, it should be noted that the support zone at $2,693 (34 EMA) will be the first line of defense if the price corrects. If the price breaks this zone, selling pressure could push the price down to the $2,672 (89 EMA) zone. Fundamentals: Lower-than-expected inflation data has reinforced expectations that the US Federal Reserve (FED) will continue to cut interest rates, which will weaken the USD and increase the appeal of gold as a safe-haven asset. At the same time, investors are still waiting for economic policy information after Donald Trump returns to the White House. I see gold in a short-term consolidation but has the potential to bounce if it breaks the important resistance zone. Watch the $2,728 zone closely to assess the next market momentum.
OANDA:XAUUSD
by nini_gone
Will the USD pressure last?On the 4-hour chart, gold prices remain within the uptrend channel established since late December 2024. Despite the sharp corrections in the recent session, the current price ($2,670/ounce) is still above the dynamic support zone of the EMA 34 and EMA 89, indicating that the uptrend has not been broken. However, the pressure from the USD Index – which rose to a 2-year high of 109.35 points – is causing gold to lose short-term momentum. On a closer look, the important resistance zone at $2,696/ounce, corresponding to the recent peak, has triggered strong selling pressure. Meanwhile, the RSI in previous analyses has shown signs of overbought conditions, increasing the possibility of a correction. However, the main trend line and the $2,660/ounce support zone are still acting as psychological support for the bulls. In terms of news, the strength of the USD comes from two factors: positive US economic data and high bond yields (nearly 4.8%). These yields have attracted capital flows away from gold to invest in bonds. In addition, investors are worried about financial instability before Donald Trump returns to the White House on January 20. This uncertainty could spur some gold buying to hedge against risks, creating support for gold prices in the short term. Personal trading strategy: Bullish scenario: If the price holds above the $2,660/ounce support zone, I expect the price to bounce back to test the $2,696 zone. A breakout of this zone could push the price towards the target of $2,720. Bearish scenario: If price breaks the $2,660 zone and the 89 EMA, I expect price to fall further to the $2,640/ounce support zone, or even $2,620.
OANDA:XAUUSD
by nini_gone
U Unity Among My Top 10 Picks for 2025 | Price TargetIf you haven`t bought U Unity at all time low: My price target for U in 2025 is $35, driven by the following fundamental factors: Strong Market Position in Gaming and Interactive Content: Unity maintains a dominant position in the gaming industry, with approximately 70% of the top mobile games built on its platform. The global gaming market is projected to grow significantly, driven by increasing consumer spending on mobile and interactive content. Unity's extensive reach—3.7 billion monthly downloads of applications made with Unity—positions it well to capture this growth. As the demand for high-quality gaming experiences continues to rise, Unity's technology will be integral in meeting these needs. Innovative Product Developments: The upcoming launch of Unity 6 promises to enhance the platform's stability and performance, which is crucial for attracting new developers and retaining existing customers. Additionally, Unity's shift back to a subscription-based model has shown positive results, with subscription revenue growing by 12%. This focus on innovation and customer satisfaction is expected to drive user engagement and revenue growth in the coming years. Focus on Operational Efficiency and Cost Management: Unity's recent restructuring efforts have significantly reduced net losses, from $291 million in Q1 2024 to $126 million in Q2 2024. This focus on operational efficiency not only improves profitability but also enhances cash flow management—Unity generated $115 million in free cash flow in Q3 2024. As the company continues to streamline operations while investing in growth initiatives, it is likely to see further improvements in financial performance. Valuation Potential Amidst Market Recovery: Despite recent challenges, Unity's current valuation presents an attractive opportunity for investors. Analysts are optimistic about the company's long-term growth prospects, particularly as it adapts to market demands and enhances its product offerings. With a target price suggesting significant upside potential from current levels, Unity is positioned for substantial appreciation as it executes its strategic vision.
NYSE:ULong
by TopgOptions
MRNA Moderna Among My Top 10 Picks for 2025 | Price TargetIf you haven`t bought MRNA on the recent breakout: My price target for MRNA in 2025 is $55, driven by the following fundamental factors: Innovative mRNA Technology and Expanding Pipeline: Moderna has established itself as a leader in mRNA technology, initially gaining prominence through its COVID-19 vaccine. The company is now leveraging this innovative platform to develop a diverse array of therapeutic candidates, with approximately 40 development projects in progress across various fields, including infectious diseases, oncology, and rare genetic disorders. This broad pipeline not only enhances Moderna's potential for future revenue but also positions it to capitalize on emerging healthcare needs as the demand for advanced therapies continues to rise. Projected Revenue Growth: Despite facing financial challenges, including recent losses, Moderna's revenue outlook remains promising. The company is forecasting sales between $2.5 billion and $3.5 billion for 2025, which analysts believe could be conservative given the anticipated rollout of new vaccines and treatments. If successful, these products could significantly boost sales and profitability, driving investor confidence and stock price appreciation 16. Market projections suggest that if Moderna successfully navigates its clinical trials and product launches, the stock could reach around $80 per share by 2025. Strategic Partnerships and Collaborations: Moderna's strategic collaborations with major pharmaceutical companies enhance its development capabilities and market access. These partnerships are crucial for accelerating product development and increasing the adoption of its mRNA technology across various therapeutic areas. By aligning with established players in the industry, Moderna can leverage additional resources and expertise to bring its innovations to market more effectively. Market Sentiment and Recovery Potential: Currently trading at lower valuations due to past performance fluctuations, Moderna's stock is positioned for recovery as investor sentiment shifts with positive developments in its pipeline. The company's five-year growth trajectory shows resilience despite recent setbacks, indicating potential for a rebound as new products come to market. Analysts remain optimistic about Moderna's long-term prospects, suggesting that as the market recognizes the value of its innovative therapies, the stock could see substantial gains.
NASDAQ:MRNALong
by TopgOptions
3
VINU Vita Inu - New Meme Coin with real world utilityVINU Vita Inu is a groundbreaking memecoin setting new standards with zero fees and smart contracts. Unlike its counterparts, VINU combines real-world utility with exceptional efficiency. With instant settlement and the highest energy efficiency in the market, VINU operates without the burden of transaction fees. Remarkably, VINU's entire coin supply is already in circulation, ensuring no further dilution. This streamlined approach supports a market capitalization of just $14.5 million, positioning VINU as a nimble and potentially high-growth opportunity in the evolving crypto landscape.
Long
by TopgOptions
MRVL Marvell Technology Options Ahead of EarningsIf you haven`t bought the MRVL before the previous earnings: Now analyzing the options chain and the chart patterns of MRVL Marvell Technology prior to the earnings report this week, I would consider purchasing the 95usd strike price Calls with an expiration date of 2024-12-6, for a premium of approximately $3.70. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
NASDAQ:MRVLLong
by TopgOptions
3
BTC Bitcoin Bear Market If you haven`t bought BTC before the recent rally: Historically, Bitcoin has shown a tendency to retrace in December before starting a recovery around March. This pattern could repeat this season, with BTC facing selling pressure as year-end portfolio rebalancing and macro uncertainties weigh on the market. While a brief Santa Claus rally might provide temporary relief, the bearish trend is expected to dominate until March. By then, BTC could trade below $84K before regaining momentum, aligning with its historical recovery trend as market conditions stabilize in spring.
Short
by TopgOptions